Connect with us

Technology

Facebook 4Q Earnings Per Shares Surge 46 Percent

Published

on

Facebook mobile users

Facebook shares surged early Thursday after easily topping Wall Street’s most optimistic estimates for both revenue and earnings in the fourth quarter.

Shares of the social media giant jumped 14 percent in premarket trading. (Get the latest quote here.)

The social media giant reported that it earned 79 cents per share on $5.84 billion in revenue in the quarter. The highest estimates on the Street had called for earnings of 75 cents and revenue of $5.67 billion, according to data from Thomson Reuters.

On average, analysts had expected Facebook to report fourth-quarter earnings of about 68 cents a share on $5.37 billion in revenue, according to Thomson Reuters.

“2015 was a great year for Facebook. Our community continued to grow and our business is thriving,” Mark Zuckerberg, Facebook founder and CEO, said in the company’s earnings release.

Facebook shares surged early Thursday after easily topping Wall Street’s most optimistic estimates for both revenue and earnings in the fourth quarter.

Shares of the social media giant jumped 14 percent in premarket trading. (Get the latest quote here.)

The social media giant reported that it earned 79 cents per share on $5.84 billion in revenue in the quarter. The highest estimates on the Street had called for earnings of 75 cents and revenue of $5.67 billion, according to data from Thomson Reuters.

On average, analysts had expected Facebook to report fourth-quarter earnings of about 68 cents a share on $5.37 billion in revenue, according to Thomson Reuters.

“2015 was a great year for Facebook. Our community continued to grow and our business is thriving,” Mark Zuckerberg, Facebook founder and CEO, said in the company’s earnings release.

Shares in the company jumped more than 12 percent in after-hours trading. Even the stock of social media competitors like LinkedIn and Twitter traded higher Wednesday after the bell.

The company’s fourth-quarter earnings per share rose 46 percent from 54 cents the year-ago period, and its revenue was nearly 52 percent higher than the $3.85 billion it recorded in Q4 2014.

In total for the full year 2015, Facebook said its revenue came in at $17.93 billion — an increase of 44 percent year-over-year.

“It’s doom and gloom all around us and these guys are just killing it,” Kevin Landis, CEO and chief investment officer at Firsthand Capital Management, told CNBC’s “Closing Bell.” “One of the really impressive things about this is: Look at all the other companies in this space, and there’s train wreck out there.”

Facebook also topped estimates for its users, reporting that it saw total monthly active users (MAUs) at about 1.59 billion by the end of the quarter. Wall Street was looking for the social media giant to report total MAUs of about 1.58 billion.

Focusing in on mobile users, the company said it saw 1.44 billion mobile MAUs — which beat the Street’s expectation of 1.43 billion, according to StreetAccount.

For the first time, more than 90 percent of both monthly and daily active users were on mobile, according to the company.

On the company’s earnings call, Zuckerberg said users watch 100 million hours of video daily on the platform, and that the company is “exploring ways to give people a dedicated place on Facebook for when they just want to watch videos” — potentially hinting at a competitor for Alphabet’s YouTube.

The CEO also said the company is working to improve its Facebook Lite app for low bandwidth environments (like in developing countries), and that it now has more than 80 million users.

Speaking with CNBC after the quarterly announcement, Facebook COO Sheryl Sandberg said she sees consumers making the shift to mobile, and that the company is no longer having conversations with business about if they should advertise on mobile, but how to best employ the platform.

“Certainly economic uncertainty in the broad macroeconomic environment affects all businesses, it affects our clients, it affects us, but that said we think we’re really well positioned to continue to take advantage of and double down on the shift to mobile which is happening,” she said. “We also know we have a lot of hard work ahead of us.”

On the advertising revenue, Facebook also beat analysts’ average expectation of $5.15 billion — according to StreetAccount — with a blow-out $5.64 billion in the quarter. Mobile advertising revenue, meanwhile, came in at $4.51 billion, Facebook said, against expectations of $4.09 billion.

Mobile advertising revenue represented about 80 percent of all ad revenue, the company said, compared to about 69 percent in the year-ago period. Ad impressions on mobile, meanwhile, increased 29 percent on a year-over-year basis, Facebook CFO David Wehner said, adding that 2015’s final quarter was the first since Q3 2013 in which total ad impressions increased against the year-ago period.

There are now more than 2.5 million active advertisers working with Facebook, Zuckerberg said on the call.

For the fourth quarter, Facebook saw average revenue per user (ARPU) of about $3.73, while Wall Street had only expected $3.43, according to StreetAccount.

“The revenue per user is an important number, but I always kind of look at usage more than users,” said Martin Pyykkonen, senior research analyst at Rosenblatt Securities. “Facebook is getting to a deceleration in that, but the average revenue was still very strong.”

Despite the quarter’s strong revenue figures, Wehner cited the strengthening U.S. dollar’s “unfavorable impact” on the company’s financials. Had exchange rates remained constant with the year-ago period’s levels, total revenue would have been about $320 million higher, Wehner said on the call.

That strong dollar will continue to affect comparisons, he predicted, saying that Facebook expects “to continue to face foreign exchange headwinds, especially early in the year, as we will be lapping periods where the dollar was relatively weaker than it is today.”

More broadly, Wehner predicted that the company will also face “tougher” comparisons throughout 2016 given the “remarkably strong advertising performance” last year.

Looking at the global macroeconomic environment — which has recently given many companies trouble — Wehner said Facebook did not see anything in its fourth quarter that indicated “broad-based macro weakness” beyond currency effects.

Beyond the flagship Facebook platform, investors also closely watch the growth of its WhatsApp and Instagram services. Earlier this month, WhatsApp said it would no longer charge annual subscription fees and would begin testing ways for users to communicate directly with businesses.

“We are really pleased with the growth in the advertiser adoption on Instagram,” Sandberg told CNBC, revealing that 98 of the company’s top 100 Facebook marketers are also now on Instagram.
On the call, Zuckerberg said WhatsApp ended the year with nearly 1 billion monthly active users.

The company’s moonshots are also in focus, with analysts wondering about the upside potential from its work in virtual reality and big data.

“We believe it is entirely plausible that VR is the future of computing,” Robert Peck, managing director and Internet equity analyst at SunTrust Robinson Humphrey, wrote in a recent note, adding it has “the potential to disrupt several diverse businesses.”

On the Oculus virtual reality platform, Zuckerberg didn’t mince his words.

“Yes I am happy. I don’t show much joy, but I am happy,” he said. “It’s going to be gaming — for the beginning. That’s the initial market…I think it’s around 250 million people who have Xboxes, Playstations or Wiis. That’s the initial market of folks who we think are going to be most interested in the early VR experiences, especially at some of the higher price points.”

“But the reason why we’re interested in this, as the social company, is that we think this is going to be a new way that people interact,” Zuckerberg explained. “We’re very excited about that: That’s going to be a big area of investment for us, and is ultimately, I think, going to change the way that we communicate, and live and work — in addition to how we play games.”

CNBC

CEO/Founder Investors King Ltd, a foreign exchange research analyst, contributing author on New York-based Talk Markets and Investing.com, with over a decade experience in the global financial markets.

Technology

Biotech Firm Launches Lassa Vaccine Trial in West Africa

Published

on

Lassa Fever

Biotech Firm Launches Lassa Vaccine Trial in West Africa

A biotechnology company, INOVIO, says the first participant in Lassa vaccine trial has been dosed in a Phase 1B clinical trial for INO-4500, its DNA vaccine candidate for Lassa fever.

The clinical trial is being done in Ghana, the firm says, adding that INOVIO is focused on bringing to market precisely-designed DNA medicines to treat and protect people from infectious diseases and cancer.

The Phase 1B clinical trial (LSV-002), ongoing at the Noguchi Memorial Institute for Medical Research in Accra, Ghana, is the first vaccine clinical trial for Lassa Fever to be conducted in West Africa, where the infection is endemic.

The lead clinical Principal Investigator for LSV-002 is Professor Dr. Kwadwo A. Koram, an expert and specialist in tropical medicines and epidemiologist with more than 20 years of research experience, including malaria vaccines.

INO-4500 was also the first vaccine candidate for Lassa fever to enter human trials, PUNCH Healthwise reports.

Already, the Director-General of the Nigeria Centre for Disease Control, Dr. Chikwe Ihekweazu, has tweeted his commendation.

Said Ihekweazu, “Fantastic news. The urgency of now. A vaccine for Lassa fever. We have worked very hard with WHO, CEPI vaccines, ACEGID, BNITM_de and many others to put this on the global health agenda. We will keep pushing.”

According to a press release by the biotechnology company, INOVIO is advancing INO-4500 with full funding from the Coalition for Epidemic Preparedness Innovations (CEPI), a global partnership that leverages funding from public, private, philanthropic and civil society organisations to support research projects to develop vaccines against emerging infectious diseases.

INOVIO previously received a $56m grant from CEPI in 2018, under which the company is developing vaccine candidates for Lassa Fever and Middle East Respiratory Syndrome (MERS).

“INOVIO and CEPI are committed to making a vaccine available as soon as possible for emergency use as a stockpile product post-Phase 2 testing,” the press release stated.

The statement notes that INOVIO’s Phase 1B clinical trial, LSV-002, will enroll approximately 220 adult participants who are 18 – 50 years old, with the primary endpoints of evaluating safety and immunogenicity in an African population.

The dosing regimen involves two vaccinations at zero and 28 days with either 1.0 mg or 2.0 mg dosing levels. In addition to providing valuable insights on the INO-4500 safety and immunogenicity profile, this trial will inform dose selection for subsequent Phase 2 studies in West Africa.

Lassa fever is an animal-borne, acute hemorrhagic viral illness primarily observed in parts of West Africa.

Infection is spread through contact with infected rodents, as well as person-to-person transmission via bodily fluids (primarily in health care settings).

The disease can cause a range of outcomes, including fever, vomiting, and swelling of the face, pain in the chest, back and abdomen, bleeding of various parts of the body including the eyes and nose and death.

Lassa virus infection in West Africa is estimated to affect 100,000 to 300,000 people annually, and is responsible for 10 – 16 percent of hospital admissions in the region. The virus is responsible for approximately 5,000 deaths annually.

Because of difficulties in diagnosing Lassa fever, the lack of standardised surveillance assays, and the remote nature of many of the areas in West Africa where outbreaks typically occur, the numbers of reported cases and deaths are very likely significantly lower than the actual numbers of cases and deaths.

Though the majority (about 80 percent) of Lassa virus-infected persons are asymptomatic or have mild symptoms, the infection can be quite serious to fatal in others. The case-fatality among patients hospitalized for Lassa fever is about 15 – 20 percent and, in some epidemics, case-fatality has reached 50 percent in hospitalized patients.

Up until now, there are no licensed vaccines or treatments specifically for Lassa fever.

Continue Reading

Technology

Google Says It Will Start Accepting Political Ads in US

Published

on

A logo is pictured at Google's European Engineering Center in Zurich

Google Says It Will Start Accepting Political Ads in US

Google has said it will resume accepting all political advertisements in the United States from Feb. 24.

The search giant disclosed in an email to advertisers on Monday.

Google paused all political advertisements in January when Trump’s mobs invaded U.S. Capitol.

Continue Reading

Technology

Elon Musk’s SpaceX Raised $850 Million at $74 Billion Valuation

Published

on

Elon Musk's SpaceX Raised $850 million at $74 billion valuation

Elon Musk’s SpaceX Raised $850 Million at $74 Billion Valuation

Elon Musk‘s SpaceX completed a $850 million equity funding round last week, according to people familiar with the funding.

According to the sources, SpaceX raised the $850 million at $419.99 per share or just 1 cent below the $420 price that Musk made infamous in 2018 when he announced he had enough funding to take Tesla private at that price.

The new funding round also represents an increase of around 60 percent in the firm’s valuation from its previous round in August, when SpaceX raised almost $2 billion at a $46 billion valuation.

SpaceX raised only a portion of the funding available in the marketplace, with one of the sources familiar with the funding saying, SpaceX received “insane demand” of around $6 billion in bids in three days.

 

Continue Reading

Trending